By the same authors

From the same journal

Achieving Biocompatible SABRE: An in vitro Cytotoxicity Study

Research output: Contribution to journalArticlepeer-review

Full text download(s)

Published copy (DOI)



Publication details

DateAccepted/In press - 12 Dec 2017
DateE-pub ahead of print (current) - 12 Dec 2017
Number of pages9
Early online date12/12/17
Original languageEnglish


Production of a biocompatible hyperpolarized bolus for signal amplification by reversible exchange (SABRE) could open the door to simple clinical diagnosis via magnetic resonance imaging. Essential to successful progression to preclinical/clinical applications is the determination of the toxicology profile of the SABRE reaction mixture. Herein, we exemplify the cytotoxicity of the SABRE approach using invitro cell assays. We conclude that the main cause of the observed toxicity is due to the SABRE catalyst. We therefore illustrate two catalyst removal methods: one involving deactivation and ion-exchange chromatography, and the second using biphasic catalysis. These routes produce a bolus suitable for future invivo study.

Bibliographical note

© 2018, The Authors.

    Research areas

  • Biocompatibility, Biphasic catalysis, Cytotoxicity, Hyperpolarization, SABRE


Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations